Presentation is loading. Please wait.

Presentation is loading. Please wait.

Nicotine Induces Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor by α1 Nicotinic Acetylcholine Receptor–Mediated Activation in.

Published byAntonin Sylvain Modified over 5 years ago

Similar presentations

Presentation on theme: "Nicotine Induces Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor by α1 Nicotinic Acetylcholine Receptor–Mediated Activation in."— Presentation transcript:

1 Nicotine Induces Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor by α1 Nicotinic Acetylcholine Receptor–Mediated Activation in PC9 Cells  Shuo Wang, MD, Koichi Takayama, MD, PhD, Kentaro Tanaka, MD, PhD, Masafumi Takeshita, MD, PhD, Noriaki Nakagaki, MD, PhD, Kayo Ijichi, MD, Heyan Li, MD, Yoichi Nakanishi, MD, PhD  Journal of Thoracic Oncology  Volume 8, Issue 6, Pages (June 2013) DOI: /JTO.0b013e31828b51d4 Copyright © 2013 International Association for the Study of Lung Cancer Terms and Conditions

2 FIGURE 1 A, NSCLC cell lines express nAChR mRNA and protein. Detection of reverse-transcriptase polymerase chain reaction products for α1 nAChR subunits in A549, H2122, and PC9 cell lines. The BEAS 2B cell line was a positive control. Products were sequenced and in each case confirmed to be the expected authentic sequence for each subunit. M, 100 bp molecular marker with the brightest band at 600 bp. B, Western blot results for α1 nAChR subunits. NSCLC cell lines express nAChR protein. BEAS 2B cell line or HEK293 cell line served as the positive or negative control, respectively. nAChR, nicotine acetylcholine receptors; NSCLC, non–small-cell lung cancer. Journal of Thoracic Oncology 2013 8, DOI: ( /JTO.0b013e31828b51d4) Copyright © 2013 International Association for the Study of Lung Cancer Terms and Conditions

3 FIGURE 2 Representative photographs of tissue microarrays showing that non–small-cell lung cancer tissue expressed α1 nicotine acetylcholine receptors. Dark-brown staining was indicative of the presence of α1 protein, and tissue was counterstained to indicate nuclei with dark-blue staining. A, adenocarcinoma ×400; (B), squamous cell carcinoma ×400; (C), large-cell carcinoma ×400; and (D), small-cell carcinoma ×400. Journal of Thoracic Oncology 2013 8, DOI: ( /JTO.0b013e31828b51d4) Copyright © 2013 International Association for the Study of Lung Cancer Terms and Conditions

4 FIGURE 3 A, Induction of Erk, Akt (Ser-473) and STAT3 phosphorylation by nicotine. PC9 cells were serum-starved for 24 hours then incubated with 10 µM of nicotine for the number of times indicated (upper panel). Western blot analysis was used to reveal the time-dependent phosphorylation of ERK and Akt (Ser-473); (B) Induction of Erk and Akt (Ser-473) phosphorylation was dependent on α1 nAChR. PC9 cells were transfected with siRNA against α1 nAChR subunit (si-α1) or NT siRNA for 72 hours. Western blot analysis revealed the difference in phosphorylated levels of ERK1/2 (p-ERK1/2) and Akt (p-Akt) between cells treated with siRNA α1 and NT; (C) Induction of EFGR phosphorylation by nicotine. PC9 cells were serum-starved for 24 hours then incubated with 10 µM of nicotine for the number of times indicated (upper panel). Western blot analysis shows the EGFR and p-EGFR protein levels; (D) Role of α1 nAChR subunit in the EFGR signaling pathway. PC9 cells were transfected with siRNA against the α1 nAChR subunits (si-α1) or NT siRNA for 72 hours. Western blot analysis shows EGFR and p-EGFR protein levels. EFGR, epidermal growth factor receptor; ERK, extracellular signal-regulated kinase; nAChR, nicotinic acetylcholine receptor; NT, nontargeting. Journal of Thoracic Oncology 2013 8, DOI: ( /JTO.0b013e31828b51d4) Copyright © 2013 International Association for the Study of Lung Cancer Terms and Conditions

5 FIGURE 4 A, Gene silencing of α1 nAChR was validated by reverse transcription PCR in PC9 cells. α1 nAChR mRNA expression was knocked down by siRNA; (B) The relative levels of α1 nAChR mRNA measured by real-time-PCR in control NT and α1 nAChR knockdown (si-α1) PC9 cells. Data are presented as mean ± standard error mean of three independent experiments carried out in triplicate. *p < nAChR, nicotinic acetylcholine receptor; NT, nontargeting; PCR, polymerase chain reaction. Journal of Thoracic Oncology 2013 8, DOI: ( /JTO.0b013e31828b51d4) Copyright © 2013 International Association for the Study of Lung Cancer Terms and Conditions

6 FIGURE 5 A, Nicotine protects NSCLC cells from cytotoxicity induced by EGFR-TKI. NSCLC PC9 cells were pretreated with 1 µM of nicotine for 1 month or 10 µM of nicotine for 1 day. Cells were then treated with EGFR-TKI for 48 hours. Cell survival was measured with the MTS assay and was expressed as a percentage of the untreated control. The concentrations of EGFR-TKI were increased in increments as indicated. Data are presented as mean ± standard error mean of three independent experiments carried out in triplicate. *p < 0.05; **p < 0.01; ***p < B, α1 nAChR subunit mediated EGFR-TKI resistance induced by long-term nicotine exposure. PC9 cells were pretreated with 1µM of nicotine for 1 month, then transfected with siRNA against α1 nAChR subunit (si-α1) or nontargeting siRNA NT for 72 hours. Cell survival was measured with the MTS assay and is expressed as a percentage of the untreated control. The concentrations of EGFR-TKI were increased in increments as indicated. Data are presented as mean ± standard error mean of three independent experiments carried out in triplicate. *p < 0.05; **p < 0.01; ***p < EFGR-TKI, epidermal growth factor receptor tyrosine kinase inhibitor; NSCLC, non–small-cell lung cancer; NT, nontargeting. Journal of Thoracic Oncology 2013 8, DOI: ( /JTO.0b013e31828b51d4) Copyright © 2013 International Association for the Study of Lung Cancer Terms and Conditions

Download ppt "Nicotine Induces Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor by α1 Nicotinic Acetylcholine Receptor–Mediated Activation in."

Similar presentations

Nicotinamide Phosphoribosyltransferase: A Potent Therapeutic Target in Non-small Cell Lung Cancer with Epidermal Growth Factor Receptor-Gene Mutation 

Nicotinamide Phosphoribosyltransferase: A Potent Therapeutic Target in Non-small Cell Lung Cancer with Epidermal Growth Factor Receptor-Gene Mutation 
Inducible EGFR T790M-Mediated Gefitinib Resistance in Non-small Cell Lung Cancer Cells Does Not Modulate Sensitivity to PI103 Provoked Autophagy  Flavia.

Inducible EGFR T790M-Mediated Gefitinib Resistance in Non-small Cell Lung Cancer Cells Does Not Modulate Sensitivity to PI103 Provoked Autophagy  Flavia.
Src-Family Kinases Are Activated in Non-Small Cell Lung Cancer and Promote the Survival of Epidermal Growth Factor Receptor-Dependent Cell Lines  Jie.

Src-Family Kinases Are Activated in Non-Small Cell Lung Cancer and Promote the Survival of Epidermal Growth Factor Receptor-Dependent Cell Lines  Jie.
IL-18 Downregulates Collagen Production in Human Dermal Fibroblasts via the ERK Pathway  Hee Jung Kim, Seok Bean Song, Jung Min Choi, Kyung Moon Kim,

IL-18 Downregulates Collagen Production in Human Dermal Fibroblasts via the ERK Pathway  Hee Jung Kim, Seok Bean Song, Jung Min Choi, Kyung Moon Kim,
Expression of LKB1 tumor suppressor in non–small cell lung cancer determines sensitivity to 2-deoxyglucose  Landon J. Inge, PhD, Keith D. Coon, PhD, Michael.

Expression of LKB1 tumor suppressor in non–small cell lung cancer determines sensitivity to 2-deoxyglucose  Landon J. Inge, PhD, Keith D. Coon, PhD, Michael.
Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome  Xiao Li, MD, Liyan Wan, MD, Jian Geng, MD, Chin-Lee.

Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome  Xiao Li, MD, Liyan Wan, MD, Jian Geng, MD, Chin-Lee.
Overexpression of CRM1: A Characteristic Feature in a Transformed Phenotype of Lung Carcinogenesis and a Molecular Target for Lung Cancer Adjuvant Therapy 

Overexpression of CRM1: A Characteristic Feature in a Transformed Phenotype of Lung Carcinogenesis and a Molecular Target for Lung Cancer Adjuvant Therapy 
INHBA Overexpression Promotes Cell Proliferation and May Be Epigenetically Regulated in Esophageal Adenocarcinoma  Christopher W. Seder, MD, Wibisono.

INHBA Overexpression Promotes Cell Proliferation and May Be Epigenetically Regulated in Esophageal Adenocarcinoma  Christopher W. Seder, MD, Wibisono.
The Autophagy Inhibitor Chloroquine Overcomes the Innate Resistance of Wild-Type EGFR Non-Small-Cell Lung Cancer Cells to Erlotinib  Yiyu Zou, PhD, Yi-He.

The Autophagy Inhibitor Chloroquine Overcomes the Innate Resistance of Wild-Type EGFR Non-Small-Cell Lung Cancer Cells to Erlotinib  Yiyu Zou, PhD, Yi-He.
NDRG1/Cap43/Drg-1 may Predict Tumor Angiogenesis and Poor Outcome in Patients with Lung Cancer  Koichi Azuma, MD, PhD, Akihiko Kawahara, PhD, Satoshi.

NDRG1/Cap43/Drg-1 may Predict Tumor Angiogenesis and Poor Outcome in Patients with Lung Cancer  Koichi Azuma, MD, PhD, Akihiko Kawahara, PhD, Satoshi.
Group IIa secretory phospholipase expression correlates with group IIa secretory phospholipase inhibition–mediated cell death in K-ras mutant lung cancer.

Group IIa secretory phospholipase expression correlates with group IIa secretory phospholipase inhibition–mediated cell death in K-ras mutant lung cancer.
Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR- Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients.

Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR- Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients.
WT1 Promotes Invasion of NSCLC via Suppression of CDH1

WT1 Promotes Invasion of NSCLC via Suppression of CDH1
Inactivation of Both FHIT and p53 Cooperate in Deregulating Proliferation-Related Pathways in Lung Cancer  Francesca Andriani, PharmD, Elena Roz, MD,

Inactivation of Both FHIT and p53 Cooperate in Deregulating Proliferation-Related Pathways in Lung Cancer  Francesca Andriani, PharmD, Elena Roz, MD,
Ginkgo biloba extract inhibits oxidized low-density lipoprotein (oxLDL)-induced matrix metalloproteinase activation by the modulation of the lectin-like.

Ginkgo biloba extract inhibits oxidized low-density lipoprotein (oxLDL)-induced matrix metalloproteinase activation by the modulation of the lectin-like.
EGFR Array: Uses in the Detection of Plasma EGFR Mutations in Non–Small Cell Lung Cancer Patients  Irene Yam, BSc, David Chi-Leung Lam, MBBS, PhD, Kaimin.

EGFR Array: Uses in the Detection of Plasma EGFR Mutations in Non–Small Cell Lung Cancer Patients  Irene Yam, BSc, David Chi-Leung Lam, MBBS, PhD, Kaimin.
Knockdown of secretory phospholipase A2 IIa reduces lung cancer growth in vitro and in vivo  Jessica A. Yu, MD, David Mauchley, MD, Howard Li, MD, Xianzhong.

Knockdown of secretory phospholipase A2 IIa reduces lung cancer growth in vitro and in vivo  Jessica A. Yu, MD, David Mauchley, MD, Howard Li, MD, Xianzhong.
Rafal Dziadziuszko, MD, PhD, Anh T

Rafal Dziadziuszko, MD, PhD, Anh T
TWEAK/Fn14 Activation Contributes to the Pathogenesis of Bullous Pemphigoid  Yale Liu, Lingling Peng, Liang Li, Chengfei Liu, Xiao Hu, Shengxiang Xiao,

TWEAK/Fn14 Activation Contributes to the Pathogenesis of Bullous Pemphigoid  Yale Liu, Lingling Peng, Liang Li, Chengfei Liu, Xiao Hu, Shengxiang Xiao,
MET Exon 14 Skipping Mutations in Lung Adenocarcinoma: Clinicopathologic Implications and Prognostic Values  Geun Dong Lee, MD, PhD, Seung Eun Lee, MD,

MET Exon 14 Skipping Mutations in Lung Adenocarcinoma: Clinicopathologic Implications and Prognostic Values  Geun Dong Lee, MD, PhD, Seung Eun Lee, MD,

Similar presentations

Ads by Google